In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites.

Composite materials have been prepared from bioactive glass powders in the SiO(2)-CaO-P(2)O(5) system, a biodegradable polymer [poly(L-lactic acid) (PLA)], a biostable polymer [polymethylmethacrylate (PMMA)], and an antibiotic [gentamicin]. The purpose of such composites is to obtain implantable materials that are able to lead to bone growth and also can, at the most critical inflammation-infection step, release an antibiotic. X-ray diffraction, scanning electron microscopy, X-ray energy dispersive spectroscopy, and FTIR analyses after different soaking periods in SBF demonstrated the growth of an apatite-like layer on the composite surface. Therefore the bioactive glass-polymer-antibiotic combination used in this work does not inhibit the glass bioactivity. The release of gentamicin after a soaking of the materials in SBF was followed by UV-visible spectroscopy. A fast initial release during the first 10 h of soaking, followed by a controlled release of the drug was observed.

[1]  B. O. Fowler.  Infrared studies of apatites. I. Vibrational assignments for calcium, strontium, and barium hydroxyapatites utilizing isotopic substitution , 1974 .

[2]  T. Kokubo,et al.  Direct bone formation on alumina bead composite. , 1997, Journal of biomedical materials research.

[3]  J. San Román,et al.  TiO2-polymer composites for biomedical applications. , 1997, Journal of biomedical materials research.

[4]  J. San Román,et al.  Composite biomaterials based on ceramic polymers. I. Reinforced systems based on Al2O3/PMMA/PLLA. , 1996, Journal of biomedical materials research.

[5]  M. Vallet‐Regí,et al.  XRD, SEM-EDS, and FTIR studies of in vitro growth of an apatite-like layer on sol-gel glasses. , 1999, Journal of biomedical materials research.

[6]  A. Piancastelli,et al.  Mineral evolution of bone. , 1996, Biomaterials.

[7]  G. C. Walker,et al.  Influence of shape factors on kinetics of drug release from matrix tablets. I. Theoretical. , 1974, Journal of pharmaceutical sciences.

[8]  R. Legeros.  6. Calcium Phosphates in Enamel, Dentin and Bone , 1991 .

[9]  N. Araki,et al.  Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. , 1992, The Journal of bone and joint surgery. British volume.

[10]  P Ducheyne,et al.  Bioactive glass fiber/polymeric composites bond to bone tissue. , 1998, Journal of biomedical materials research.

[11]  D. Robinson,et al.  Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides. , 1990, Journal of pharmaceutical sciences.

[12]  L. Claes,et al.  A new composite made of polyurethane and glass ceramic in a loaded implant model: a biomechanical and histological analysis , 1997, Journal of materials science. Materials in medicine.

[13]  F. Langlais,et al.  [Antibiotic release by tricalcic phosphate bone implantation. In vitro and in vivo pharmacokinetics of different galenic forms]. , 1997, Chirurgie; memoires de l'Academie de chirurgie.

[14]  J. Davies,et al.  Scanning electron microscopy of the bone-bioactive implant interface. , 1997, Journal of biomedical materials research.

[15]  Raquel Zapanta LeGeros,et al.  Apatites in biological systems , 1981 .

[16]  J. Lane,et al.  Treatment of experimental osteomyelitis with antibiotic‐impregnated bone graft substitute , 1993, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  T Kitsugi,et al.  Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. , 1990, Journal of biomedical materials research.

[18]  P. Ducheyne,et al.  Surface reaction layer formation in vitro on a bioactive glass fiber/polymeric composite. , 1997, Journal of biomedical materials research.